Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Professor, Jur. Dr., LL.M., M.I.C.L.

Karen Blixens Plads 16

Copenhagen, 2300

Denmark

http://jura.ku.dk/cebil/staff/profile/?pure=en/persons/381631

SCHOLARLY PAPERS

88

DOWNLOADS
Rank 5,498

SSRN RANKINGS

Top 5,498

in Total Papers Downloads

11,007

SSRN CITATIONS
Rank 29,627

SSRN RANKINGS

Top 29,627

in Total Papers Citations

24

CROSSREF CITATIONS

5

Scholarly Papers (88)

1.

Res Judicata in the ECJ Case Law: Balancing Legal Certainty with Legality?

European Constitutional Law Review, Issue 3, pp. 385-417, 2007
Number of pages: 33 Posted: 06 Oct 2009 Last Revised: 02 Sep 2015
Xavier Groussot and Timo Minssen
Lund University and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 916 (36,504)

Abstract:

Loading...

Res Judicata, European Court of Justice, Legal Certainty, Legality, Revision of Decisions, State Liability, Acte Clair; Kühne & Heitz, Köbler

2.

Ethical and Legal Challenges of Artificial Intelligence-Driven Healthcare

This article was published in Artificial Intelligence in Healthcare, 1st edition, Adam Bohr, Kaveh Memarzadeh (eds.), ISBN: 9780128184387, Copyright Elsevier, 2020
Number of pages: 42 Posted: 26 May 2020 Last Revised: 01 Mar 2021
Sara Gerke, Timo Minssen and I. Glenn Cohen
Pennsylvania State University, Dickinson Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Harvard Law School
Downloads 844 (40,864)
Citation 2

Abstract:

Loading...

Artificial Intelligence (AI), Ethical Challenges, U.S. and EU Law, Safety and Effectiveness, Data Protection and Privacy

3.

The Evolution of the CJEU's Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.

Published in Nordic Intellectual Property Law Review (NIR), Nr. 5, pp. 493-503 (2015).
Number of pages: 10 Posted: 13 Mar 2015 Last Revised: 25 Feb 2016
Timo Minssen and Ana Nordberg
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Faculty of Law, Lund University, Sweden
Downloads 765 (46,593)
Citation 4

Abstract:

Loading...

biotech, patents, Europe, stem cells, innovation policy

4.

The Rule of Reason under Article 82 EC after Sot Lelos Kai Sia

Number of pages: 29 Posted: 07 Jul 2009 Last Revised: 02 Sep 2015
Tu T. Nguyen, Timo Minssen and Xavier Groussot
Faculty of Law, Lund University, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University
Downloads 747 (48,134)
Citation 1

Abstract:

Loading...

rule of reason, refusal to supply, parallel trade, pharmaceutical sector, Article 82 EC

5.

The Impact of Broccoli II & Tomato II on European Patents in Conventional Breeding, GMO's and Synthetic Biology: The Grand Finale of a Juicy Patents Tale?

Biotechnology Law Report, Vol. 34, No. 3 (2015), pp. 81-98
Number of pages: 24 Posted: 19 May 2015 Last Revised: 30 Jul 2017
Timo Minssen and Ana Nordberg
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Faculty of Law, Lund University, Sweden
Downloads 699 (52,592)
Citation 1

Abstract:

Loading...

Biotechnology, Patents, Plant Science, European Patent Office, GMOs, Synthetic Biology, Conventional breeding methods, essentially biological processes, agricultural industry, CRISPR, unitary patent

6.

Research and Bolar Exemptions in the U.S. and Europe: Recent Developments and Possible Scenarios

Number of pages: 11 Posted: 30 Aug 2018
Jakob Wested and Timo Minssen
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 502 (79,947)

Abstract:

Loading...

LIfe Science, Bolar Provision, Research Exemption, Patent, TRIPS Agreement

7.

Cross-Border Transfers of Personal Data after Schrems II: Supplementary Measures and New Standard Contractual Clauses (SCCs)

Number of pages: 12 Posted: 27 Oct 2021
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, LML, University of Cambridge and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 471 (86,266)

Abstract:

Loading...

Schrems II, international data transfers, supplementary measures, new Standard Contractual Clauses (SCCs), EDPB Recommendations 01/2020, encryption, security and organisational measures, GDPR.

8.

US Patent Eligibility in the Wake of Bilski v. Kappos: 'Business as Usual' in an Age of New Technologies?

Biotechnology Law Report, Vol. 30, Nr. 1, 2011, pp. 3-56, including a sequel at pp. 57-58.
Number of pages: 77 Posted: 26 Sep 2010 Last Revised: 01 Nov 2015
Timo Minssen and Robert M. Schwartz
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University Faculty of Law
Downloads 409 (101,693)

Abstract:

Loading...

9.

Patenting Bioprinting-Technologies in the US and Europe – The 5th Element in the 3rd Dimension

“Patenting Bioprinting Technologies in the US and Europe– The 5th element in the 3rd dimension". / Minssen, Timo; Mimler, Marc. 3D printing, Intellectual Property and Innovation – Insights from Law and Technology. ed. / Rosa Maria Ballardini; Marcus Norrgård; Jouni Partanen. Wolters Kluwer , 2017.
Number of pages: 27 Posted: 08 Apr 2017 Last Revised: 21 Jul 2020
Timo Minssen and Marc Mimler
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Bournemouth University - Centre for Intellectual Property Policy & Management (CIPPM)
Downloads 399 (104,663)
Citation 1

Abstract:

Loading...

10.

Clinical Trial Data Transparency and GDPR Compliance: Implications for Data Sharing and Open Innovation

In: Katerina Sideri & Graham Dutfield (eds.), Openness, Intellectual Property and Science Policy in the Age of Data Driven Medicine, Special Issue of Science and Public Policy (2019 Forthcoming)
Number of pages: 19 Posted: 02 Jul 2019 Last Revised: 19 Jul 2019
Timo Minssen, Rajam Neethu and Marcel Bogers
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen and Eindhoven University of Technology
Downloads 394 (106,169)
Citation 2

Abstract:

Loading...

11.

The Industrial Application Requirement for Biotech Inventions in Light of Recent EPO & UK Case Law: A Plausible Approach or a Mere 'Hunting License'?

E.I.P.R. , Vol 34, Nr. 10, S. 689-703 (2012)
Number of pages: 23 Posted: 11 Sep 2014
Timo Minssen and David Nilsson
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Independent
Downloads 391 (107,125)

Abstract:

Loading...

12.

The Role of Patents and Licensing in the Governance of Human Genome Editing: A White Paper

Queen Mary Law Research Paper No. 364/2021
Number of pages: 52 Posted: 02 Aug 2021 Last Revised: 12 Aug 2021
Queen Mary University of London - School of Law, School of Law, University of Aberdeen, affiliation not provided to SSRN, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Faculty of Law, Lund University, Sweden, University of Illinois College of Law, Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Centre of Excellence GOVTRUST, University of Antwerp, Belgium and National University of Ireland, Maynooth (NUI Maynooth) - Department of Law : Ireland
Downloads 386 (108,774)

Abstract:

Loading...

13.

Legal Aspects of Biobanking as Key Issues for Personalized Medicine & Translational Exploitation

Personalized Medicine, Vol. 11, No. 5, Pages 497-508
Number of pages: 16 Posted: 18 Jan 2014 Last Revised: 31 Dec 2014
Timo Minssen and Jens Schovsbo
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Centre for Information and Innovation Law (CIIR)
Downloads 384 (109,413)

Abstract:

Loading...

biobanks, law & ethics, intellectual property, informed consent, personalized medicine, open innovation, translational medicine

14.

Addressing Exclusivity Issues During the COVID-19 Pandemic and Beyond

Forthcoming, I. Glenn Cohen, Abbe Gluck, Katherine Kraschel, & Carmel Shachar, COVID-19 and the Law: Disruption, Impact and Legacy. Cambridge University Press, 2022
Number of pages: 14 Posted: 05 Aug 2021 Last Revised: 25 Jul 2022
Michael S. Sinha, Sven Bostyn and Timo Minssen
Program On Regulation, Therapeutics, And Law (PORTAL), University of Copenhagen - Faculty of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 262 (163,970)

Abstract:

Loading...

COVID-19, innovation policy, vaccines, FDA

15.

Standardization, IPRs and Open Innovation in Synthetic Biology

Timo Minssen, and Jakob B. Wested. “Standardization, IPRs and Open Innovation in Synthetic Biology.” Innovation, Competition and Collaboration. Edward Elgar Publishing, 2015. 34–66. Web.
Number of pages: 20 Posted: 16 Feb 2014 Last Revised: 21 Jul 2020
Timo Minssen and Jakob Wested
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Centre for Advanced Studies in Biomedical Innovation Law (CeBIL)
Downloads 253 (169,744)
Citation 3

Abstract:

Loading...

standardization, open innovation, synthetic biology, intellectual property rights

16.

Meanwhile on the Other Side of the Pond: Why Biopharmaceutical Inventions that Were 'Obvious to Try' Still Might Be Non-Obvious – Part I

Chicago-Kent Journal of Intellectual Property, Vol. 9, Spring 2010
Number of pages: 72 Posted: 27 Sep 2009 Last Revised: 02 Sep 2015
Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 251 (171,042)

Abstract:

Loading...

DNA-related inventions, patentability, inventive step, non-obviousness, obvious to try, biopharmaceutical industry, US, Europe

17.

The Interaction of the Medical Device Regulation and the GDPR: Do European Rules on Privacy and Scientific Research Impair the Safety & Performance of AI Medical Devices?

In: I. Glenn Cohen, Timo Minssen, W. Nicholson Price II, Christopher Robertson, and Carmel Shachar. The Future of Medical Device Regulation: Innovation and Protection, Cambridge University Press
Number of pages: 12 Posted: 22 Mar 2021 Last Revised: 03 May 2021
KU Leuven, Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 250 (171,670)

Abstract:

Loading...

Medical Device Regulation, Artificial Intelligence, Privacy, GDPR, European Union

18.

Patenting Human Genes in Europe - And How It Compares to the US and Australia

Research Handbook on Intellectual Property and the Life Sciences (eds. Herbert Zech & Duncan Matthews), Chapter 1.5, Edward Elgar, 2016
Number of pages: 13 Posted: 27 Feb 2016 Last Revised: 29 Jul 2019
Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 239 (179,299)

Abstract:

Loading...

Patents, DNA, Europe, Genes

19.

A Review of 'Patents and Technological Progress in a Globalized World - Liber Amicorum Joseph Straus'

The IP Law Book Review, Vol. 2, Issue 2, January 2012
Number of pages: 12 Posted: 01 Sep 2011 Last Revised: 02 Sep 2015
Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 181 (231,327)

Abstract:

Loading...

Patents, Pharmaceuticals, Biotechnology, IPR

20.

Tackling Grand Challenges with Competition Law: Lessons from the Pandemic

in W. Sauter, M. Canoy and J. Mulder (eds), EU Competition Law and Pharmaceuticals (Edward Elgar Publishing 2022) Forthcoming.
Number of pages: 16 Posted: 15 Dec 2021
University College London - Faculty of Laws, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL)
Downloads 168 (246,306)

Abstract:

Loading...

Competition law, grand challenges, sustainable pharma, collaboration, coopetition, public health, regulatory sandboxes

21.

Restoring the Balance: The Patentability of DNA-Related Technology in the US and Europe

Number of pages: 10 Posted: 07 Oct 2009 Last Revised: 02 Sep 2015
Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 156 (262,101)

Abstract:

Loading...

patent law, private law, comparative law, intellectual property law, patents, innovation system, biotechnology, DNA, proteins

22.

Supplementary Measures and Appropriate Safeguards for International Transfers of Personal Data after Schrems II

Number of pages: 27 Posted: 06 Apr 2022
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, Kyushu University - Graduate School of Law, LML, University of Cambridge and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 152 (267,609)

Abstract:

Loading...

International transfers, cross-border transfers of personal data, homomorphic encryption (HE), multiparty processing, new standard contractual clauses (SCCs), Schrems II, supplementary measures, appropriate safeguards

23.

Technology-Driven Disruption of Healthcare & 'UI Layer' Privacy-by-Design

Cambridge Bioethics and the Law series, Cambridge University Press, Forthcoming
Number of pages: 37 Posted: 22 Jun 2020 Last Revised: 09 Sep 2020
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, Kyushu University - Graduate School of Law, University of Vaasa, School of Accounting and Finance, Business Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Tilburg University - Department of Business Law
Downloads 150 (270,474)

Abstract:

Loading...

AI, Algorithms, Apps, Data Protection, Design Patterns, GDPR, Healthcare, Legal Design, Privacy, Super Platforms, UI Layer Privacy-by-Design

24.

Book Review: Pharmaceutical Innovation, Competition and Patent Law – A Trilateral Perspective

Forthcoming in European Competition Law Review (E.C.L.R.). Issue 4, pp. 151-155 (Sweet & Maxwell 2014).
Number of pages: 6 Posted: 17 Feb 2014 Last Revised: 19 Feb 2014
Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 141 (284,041)

Abstract:

Loading...

Pharmaceutical law, Health law, Competition law, Innovation

25.

The 'Opt Out' and 'Opt-In' Provisions in the Unified Patent Court Agreement -- Impact and Strategies for European Patent Portfolios

Nordic Intellectual Property Law Review (NIR), Issue 4, pp 340-357 (2014)., University of Copenhagen Faculty of Law Research Paper No. 2015-3
Number of pages: 18 Posted: 22 Apr 2015 Last Revised: 08 Jul 2016
Timo Minssen and Bjorn Lundqvist
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Stockholm University - Faculty of Law
Downloads 129 (304,125)
Citation 1

Abstract:

Loading...

Unitary patent, IPR, strategies, patent portfolios

26.

Lost on the High Seas without a Safe Harbor or a Shield? Navigating Cross-Border Data Transfers in the Pharmaceutical Sector After Schrems II Invalidation of the EU-US Privacy Shield

European Pharmaceutical Law Review (EPLR), 4(3):153-160
Number of pages: 10 Posted: 28 Jan 2021 Last Revised: 10 Apr 2021
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Ghent, Faculty of Law and LML, University of Cambridge
Downloads 115 (330,351)

Abstract:

Loading...

GDPR, Data transfer, Schrems II case, data protection, data security, Privacy Shield, Standard Contractual Clauses (SCCs), pharmaceutical sector

27.

Homomorphic Encryption: The ‘Holy Grail’ for Big Data Analytics & Legal Compliance in the Pharmaceutical and Healthcare Sector?

European Pharmaceutical Law Review (EPLR), 3(4):144-155
Number of pages: 14 Posted: 02 Dec 2019 Last Revised: 13 Nov 2020
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, KU Leuven, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 100 (363,072)

Abstract:

Loading...

homomorphic encryption (HE), GDPR, data protection, data security, healthcare and pharmaceutical sector, big data analytics, cloud computing, algorithms, encryption, noise

28.

Confronting New Issues in Genetic Discrimination

Joly, Yann and Huerne, Katherine and Arych, Mykhailo and Bombard, Yvonne and De Paor, Aisling and Dove, Edward and Granados Moreno, Palmira and Ho, Calvin W.L. and Ho, Chih-Hsing and Van Hoyweghen, Ine and Kim, Hannah and Lebret, Audrey and Minssen, Timo and O Cathaoir, Katharina and Prince, Anya E.
Number of pages: 8 Posted: 22 Oct 2021 Last Revised: 26 Oct 2021
McGill University - Centre for Genomics and Policy, McGill University, National University of Food Technologies, University of Toronto - Institute of Health Policy, Management and Evaluation, University of Edinburgh - School of Law, McGill University - Centre for Genomics and Policy, Academia Sinica - Institute of European and American Studies, Life Sciences & Society Lab, Centre for Sociological Research, KU Leuven, Yonsei University, University of Copenhagen - Copenhagen University, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen - Faculty of Law, University of Iowa College of Law, University of Tasmania - Faculty of Law, University of Pretoria - Faculty of Law, McGill University - Department of Medicine, McGill University - Centre for Genomics and Policy, affiliation not provided to SSRN, McGill University - Centre of Genomics and Policy and McGill University - Centre of Genomics and Policy
Downloads 99 (365,471)

Abstract:

Loading...

genetic discrimination, ELSI, intersex, moratorium, insurance contract, genetic databases

29.

AIRR Data Under the E.U. Trade Secrets Directive: Aligning Scientific Practices with Commercial Realities

AIRR DATA UNDER THE E.U. TRADE SECRETS DIRECTIVE- ALIGNING SCIENTIFIC PRACTICES WITH COMMERCIAL REALITIES. / Sherkow, Jacob S.; Minssen, Timo. The harmonization and protection of trade secrets in the EU – An Appraisal of the EU Directive. ed. / Jens Schovsbo; Thomas Riis; Timo Minssen. Edward Elg, NYLS Legal Studies Research Paper No. 3249498
Number of pages: 23 Posted: 23 Oct 2018 Last Revised: 13 Jul 2020
Jacob S. Sherkow and Timo Minssen
University of Illinois College of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 92 (382,624)
Citation 1

Abstract:

Loading...

AIRR, immune receptor, antibodies, TCRs, EU, trade secrets, science, genetic data, big data, follow-on data, patents, clinical trials, diagnostics

30.

Rules and Tools in the Battle Against Superbugs - A Call for Integrated Strategies and Enhanced International Collaboration to Promote Antimicrobial Drug Development

Forthcoming in Infectious Diseases in the New Millennium: Legal and Ethical Challenges, Mark Eccleston-Turner (ed) (Springer, June, 2020)., University of Copenhagen Faculty of Law Research Paper No. 2018-58
Number of pages: 23 Posted: 02 May 2018 Last Revised: 17 Mar 2020
Timo Minssen and Ana Nordberg
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Faculty of Law, Lund University, Sweden
Downloads 92 (382,624)

Abstract:

Loading...

Sustainable Incentives, Regulation, IPRs, Antimicrobials, Antibiotics, AM Resistance

31.

TRIPS and the Life Sciences - Perspectives on Limitations to Patentability

University of Copenhagen Faculty of Law Research Paper No. 2017-37
Number of pages: 9 Posted: 16 Jun 2017 Last Revised: 08 Jul 2017
Jakob Wested and Timo Minssen
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 88 (393,282)

Abstract:

Loading...

TRIPS agreement, Patents, Correa guidelines, Technological neutrality, non-discrimination, Life science, Pharmaindustry, Biotechnology

32.

Balancing Innovation, ‘Ordre Public’ and Morality in Human Germline Editing: A Call for More Nuanced Approaches in Patent Law

Queen Mary Law Research Paper No. 379/2022
Number of pages: 27 Posted: 17 Feb 2022
Duncan Matthews, Timo Minssen and Ana Nordberg
Queen Mary University of London - School of Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Faculty of Law, Lund University, Sweden
Downloads 83 (407,215)

Abstract:

Loading...

patent law, morality exception, genome editing, genome editing governance, law and ethics, CRISPR

33.

US U-Turn on COVID IP Waiver Alone Will Not Solve Vaccine Crisis – Intellectual Property Is an Important Part of the Debate, but Greater Transparency Is Required

A shortened and edited version of this opinion was published by The Financial Times on June 17th, 2021
Number of pages: 2 Posted: 12 Aug 2021
Duncan Matthews and Timo Minssen
Queen Mary University of London - School of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 77 (425,317)

Abstract:

Loading...

Health Law, Life Science Law, Covid-19, Vaccinations

34.

The US Examination of Nonobviousness after KSR vs. Teleflex with Special Emphasis on DNA-Related Inventions

IIC, Vol. 39, No. 8, pp. 886-916, 2008
Number of pages: 32 Posted: 13 Dec 2009 Last Revised: 02 Sep 2015
Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 70 (447,905)

Abstract:

Loading...

KSR v. Telefex, Ex parte Kubin, nonobviousness, DNA-related inventions

35.

Patentability Standards for Follow-On Pharmaceutical Innovation

37 BIOTECHNOLOGY LAW REPORT 131 (2018)
Number of pages: 31 Posted: 31 Jul 2018 Last Revised: 06 May 2020
University of Missouri - Kansas City School of Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Sidley Austin LLP
Downloads 68 (454,715)
Citation 1

Abstract:

Loading...

UNDP, Patentability Guidelines, Patent Examination, Pharmaceutical Patents, TRIPS Agreement

36.

A ‘Ray of Hope’ for European Stem Cell Patents or ‘Out of the Smog into the Fog’?: An Analysis of Recent European Case Law and How It Compares to the US

IIC - International Review of Intellectual Property and Competition Law, 47(2), 138-177, Marh 2016, DOI: 10.1007/s40319-016-0449-x
Number of pages: 40 Posted: 27 Nov 2015 Last Revised: 21 Jul 2020
Ana Nordberg and Timo Minssen
Faculty of Law, Lund University, Sweden and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 65 (465,215)

Abstract:

Loading...

Stem cell patents, EU, US, Biotechnology Directive, technical expertise, general courts

37.

Procedural Aspects of Compulsory Licensing Under TRIPS: Report No. II of Webinar Series on Reinterpreting TRIPS in the Life Sciences

Number of pages: 9 Posted: 28 Sep 2017
Jakob Wested and Timo Minssen
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 56 (499,752)

Abstract:

Loading...

TRIPS, Life Science, Patents, Compulsory Licensing, Access to Medicine, NATCO

38.

Separating Sheep from Goats: A European View on the Patent Eligibility of Biomedical Diagnostic Methods

Journal of Law and the Biosciences, Vol. 3, No. 2, pp. 365-372 (2016)
Number of pages: 9 Posted: 27 Jun 2019
Timo Minssen and Robert M. Schwartz
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University Faculty of Law
Downloads 54 (507,966)
Citation 1

Abstract:

Loading...

39.

Reap What You Sow! — But What About SPC Squatting?

Journal of Intellectual Property Law & Practice, Vol. 13, No. 7, 2018, p. 569-580.
Number of pages: 12 Posted: 24 Apr 2019 Last Revised: 17 Jul 2020
Centre for Information and Innovation Law (CIIR), University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Inspicos P/S
Downloads 54 (507,966)

Abstract:

Loading...

40.

An Update on Research- & Bolar Exemptions in the U.S. and Europe: Unsolved Questions and New Developments in an Increasingly Important Area of Law

NIR: Nordiskt Immateriellt Rättsskydd, Vol. 2019, No. 2, pp. 168-183
Number of pages: 12 Posted: 25 Apr 2019 Last Revised: 16 Jul 2020
Jakob Wested and Timo Minssen
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 46 (543,669)

Abstract:

Loading...

41.

Life after Myriad: The Uncertain Future of Patenting Biomedical Innovation & Personalized Medicine in an International Context

Intellectual Property Quarterly, Vol. 2015, Nr. 3, 08.2015, s. 189-241.
Number of pages: 59 Posted: 21 Jun 2015 Last Revised: 21 Jul 2020
Robert M. Schwartz and Timo Minssen
Lund University Faculty of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 38 (583,934)
Citation 1

Abstract:

Loading...

Biotechnology, US, Europe, Australia, Comparative Law, DNA, Myriad, patent-eligibility, personalized medicine, genetic diagnostics, USPTO 2014 Guidelines, methods, innovation, Unified Patent Court

42.

Cutting Edges and Weaving Threads in the Gene Editing (Я)Evolution: Reconciling Scientific Progress with Legal, Ethical, & Social Concerns

Number of pages: 50 Posted: 14 Sep 2017 Last Revised: 17 Jul 2020
Faculty of Law, Lund University, Sweden, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen - Department of Media, Cognition and Communication, University of Copenhagen - Department of Media, Cognition and Communication, Niels Bohr Institute, University of Copenhagen and University of Copenhagen - Centre for Synthetic Biology
Downloads 29 (637,273)

Abstract:

Loading...

Gene editing; Gene Drive; CRISPR/Cas9; Patents; Regulation; Interdisciplinary perspectives; Ethical and social concerns; law and technology; ELSI

43.

Enforcing Patents in the Era of 3D Printing

Rosa Maria Ballardini, Marcus Norrgård, Timo Minssen, Enforcing patents in the era of 3D printing, Journal of Intellectual Property Law & Practice, Volume 10, Issue 11, November 2015, Pages 850–866, https://doi.org/10.1093/jiplp/jpv152
Number of pages: 17 Posted: 06 Dec 2015 Last Revised: 21 Jul 2020
University of Helsinki - IPR University Center, University of Helsinki and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 29 (637,273)
Citation 3

Abstract:

Loading...

3D printing, patents, IPR, enforcement

44.

How Much Is Too Much?: Defining the Metes and Bounds of Excessive Pricing in the Pharmaceutical Sector

European Pharmaceutical Law Review Volume 2 (2018), Issue 3, Pages 133 - 148
Number of pages: 16 Posted: 16 Nov 2018 Last Revised: 09 Jan 2021
Behrang Kianzad and Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 23 (679,849)

Abstract:

Loading...

Excessive Prices, Excessive Pricing, Pharmaceutical Pricing, Competition Law, Intellectual Property Law, Patent Law, European Patent Law, Article 102, TRIPS

45.

IPRs in Biobanking - Risks and Opportunities for Translational Research

Intellectual Property Quarterly, Vol. 2015, No.2, pp.106-129
Number of pages: 25 Posted: 27 Jun 2019 Last Revised: 21 Jul 2020
Timo Minssen, Michiel Verlinden and Isabelle Huys
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Research Centre for Pharmaceutical Care and Pharmaco-economics and affiliation not provided to SSRN
Downloads 13 (762,989)
Citation 2

Abstract:

Loading...

46.

The US Supreme Court in Mayo v. Prometheus - Taking the Fire from or to Biotechnology and Personalized Medicine? Supreme Court of the United States, Mayo Collaborative Services, dba Mayo Medical Laboratories, et al., Petitioners v Prometheus Laboratories, Inc ., 132 S.Ct. 1289

Queen Mary Journal of Intellectual Property, Vol. 2, No. 4, pp.376-388 (2012)
Number of pages: 14 Posted: 27 Jun 2019 Last Revised: 22 Jul 2020
Timo Minssen and David Nilsson
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Independent
Downloads 13 (762,989)
Citation 2

Abstract:

Loading...

47.

Intellectual property rights, standards and data exchange in systems biology

Zimmeren, Esther, Berthold Rutz, and Timo Minssen. “Intellectual Property Rights, Standards and Data Exchange in Systems Biology.” Biotechnology Journal 11.12 (2016): 1477–1480. Web.
Number of pages: 6 Posted: 30 Jun 2019 Last Revised: 21 Jul 2020
Centre of Excellence GOVTRUST, University of Antwerp, Belgium, European Patent Office and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 11 (781,829)
Citation 1

Abstract:

Loading...

48.

Unlocking the Full Potential of Open Innovation in the Life Sciences Through a Classification System

Drug Discovery Today, Vol. 23, No. 4, 01.04.2018, p. 771-775.
Number of pages: 6 Posted: 24 Apr 2019 Last Revised: 16 Jul 2020
Niclas Nilsson and Timo Minssen
affiliation not provided to SSRN and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 10 (791,505)

Abstract:

Loading...

49.

Reconciling IPRs and Openness in Biobanking

European Intellectual Property Review, Vol. 38, No. 1, pp. 1-4, 2016
Number of pages: 6 Posted: 27 Jun 2019 Last Revised: 21 Jul 2020
Michiel Verlinden, Timo Minssen and Isabelle Huys
Research Centre for Pharmaceutical Care and Pharmaco-economics, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and affiliation not provided to SSRN
Downloads 9 (801,349)
Citation 1

Abstract:

Loading...

50.

Ten Simple Rules for a Successful Cross-Disciplinary Collaboration

Knapp B, Bardenet R, Bernabeu MO, Bordas R, Bruna M, Calderhead B, et al. (2015) Ten Simple Rules for a Successful Cross-Disciplinary Collaboration. PLoS Comput Biol 11(4): e1004214., DOI: 10.1371/journal.pcbi.1004214
Number of pages: 7 Posted: 28 Aug 2020
Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 8 (811,509)

Abstract:

Loading...

51.

Synthetic Biology and Intellectual Property Rights: Six Recommendations.

Minssen, Timo, Berthold Rutz, and Esther Van Zimmeren. “Synthetic Biology and Intellectual Property Rights: Six Recommendations.” Biotechnology Journal 10.2 (2015): 236–241. Web.
Number of pages: 7 Posted: 27 Feb 2016 Last Revised: 21 Jul 2020
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, European Patent Office and Centre of Excellence GOVTRUST, University of Antwerp, Belgium
Downloads 7 (821,731)
Citation 1

Abstract:

Loading...

52.
Downloads 5 (842,725)

Abstract:

Loading...

53.

Myriad Reloaded and Ready for the Next Round?

Queen Mary Journal of Intellectual Property, Vol.3, No.1, pp. 70-80 (2013)
Number of pages: 12 Posted: 27 Jun 2019 Last Revised: 22 Jul 2020
Timo Minssen and Robert M. Schwartz
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University Faculty of Law
Downloads 4 (853,945)

Abstract:

Loading...

Regulating Germline Editing in Assisted Reproductive Technology: An EU Cross‐Disciplinary Perspective

Bioethics, Vol. 34, Issue 1, pp. 16-32, 2020
Number of pages: 17 Posted: 01 May 2020
Faculty of Law, Lund University, Sweden, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Centre of Bioethical Research and Analysis (COBRA), National University of Ireland (Galway), Rep. of Ireland, affiliation not provided to SSRN, Independent and Independent
Downloads 3 (901,962)

Abstract:

Loading...

assisted reproductive technology, ethics, gene editing, germline modifications, governance, law, science and society

Regulating Germline Editing in Assisted Reproductive Technology: An EU Cross-disciplinary Perspective

Posted: 10 Dec 2018 Last Revised: 15 Jan 2020
Faculty of Law, Lund University, Sweden, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Centre of Bioethical Research and Analysis (COBRA), National University of Ireland (Galway), Rep. of Ireland, Independent, Independent and Independent

Abstract:

Loading...

Assisted Reprudution Technology, Gene Editing & Law, Human Enhancement, Bioethics & Law, Bioethics & Genetics, Techn Regulation

55.

Standing on Shaky Ground- US Patent-Eligibility of Isolated DNA and Genetic Diagnostics after AMP v. USPTO – Part III (Unsolved Questions & Subsequent Case Law)

Queen Mary Journal of Intellectual Property, Vol. 2, No. 3, pp.225-249 (2012)
Number of pages: 26 Posted: 27 Jun 2019 Last Revised: 22 Jul 2020
Timo Minssen and David Nilsson
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Independent
Downloads 2 (878,965)

Abstract:

Loading...

Challenges for the Sustainability of University-Run Biobanks

Biopreservation and Biobanking, Vol. 16, No. 4, 08.2018, p. 312-321.
Number of pages: 29 Posted: 25 Apr 2019 Last Revised: 16 Jul 2020
University of Copenhagen, University of Copenhagen, University of Copenhagen - Faculty of Law, University of Copenhagen, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen, University of Copenhagen, University of Copenhagen, University of Copenhagen and Centre for Information and Innovation Law (CIIR)
Downloads 2 (916,852)
Citation 1

Abstract:

Loading...

57.

Standing on Shaky Ground - US Patent-Eligibility of Isolated DNA and Genetic Diagnostics after AMP v. USPTO: Part I

Queen Mary Journal of Intellectual Property Law, Vol. 1, No. 3, 2011
Number of pages: 26 Posted: 29 Sep 2011 Last Revised: 22 Jul 2020
Timo Minssen and David Nilsson
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Independent
Downloads 2 (878,965)

Abstract:

Loading...

58.

Standing on Shaky Ground- US Patent-Eligibility of Isolated DNA and Genetic Diagnostics after Amp v. Uspto – Part II (Practical Implications & Chances for Supreme Court Review)

Queen Mary Journal of Intellectual Property, Vol. 2, No. 2, pp.136-157 (2012)
Number of pages: 23 Posted: 27 Jun 2019 Last Revised: 22 Jul 2020
Timo Minssen and David Nilsson
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Independent
Downloads 1 (893,458)

Abstract:

Loading...

59.

Applying the Proportionality Principle to COVID-19 Antibody Testing

Journal of Law and the Biosciences, Volume 7, Issue 1, January-June 2020, lsaa058, https://doi.org/10.1093/jlb/lsaa058
Posted: 09 Jul 2021
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Program On Regulation, Therapeutics, And Law (PORTAL), Pennsylvania State University, Dickinson Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

Proportionality Principle, COVID-19, Antibody Testing

60.

Germany’s Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries

npj Digit. Med. 3, 94 (2020). https://doi.org/10.1038/s41746-020-0306-7
Posted: 09 Jul 2021
Sara Gerke, Ariel Dora Stern and Timo Minssen
Pennsylvania State University, Dickinson Law, Harvard Business School and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

Digital Health, Germany, Apps, Digital Healthcare Act

61.

The Ethics and Laws of Medical Big Data

in The Cambridge Handbook of Information Technology, Life Sciences and Human Rights (M. Ienca, O. Pollicino, L. Liguori, E. Stefanini & R. Andorno eds., Cambridge University Press, 2022)
Posted: 04 Mar 2021 Last Revised: 15 Aug 2022
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Harvard Law School, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Pennsylvania State University, Dickinson Law

Abstract:

Loading...

Big Data, Medicine, Ethics, Ownership, Informed Consent, Privacy, Data Sharing, COVID-19, EU Law, US Law

62.

Standing on Shaky Ground- US Patent-Eligibility of Isolated DNA and Genetic Diagnostics After AMP v. USPTO – Part IV

Standing on shaky ground- US patent-eligibility of isolated DNA and genetic diagnostics after AMP v. USPTO - Part IV. / Minssen, Timo; Schwartz, Robert M. In: Queen Mary Journal of Intellectual Property, Vol. 3, No. 2, 2013, p. 118-144.
Posted: 28 Oct 2020
Timo Minssen and Robert M. Schwartz
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University Faculty of Law

Abstract:

Loading...

63.

Fighting Falsified Medicines with Paperwork – a Historic Review of Danish Legislation Governing Distribution of Medicines

Journal of Pharmaceutical Policy and Practice, Vol. 30, No. 9, 06.10.2016, p. 1-8., https://doi.org
Posted: 17 Oct 2020
Rasmus Borup and Timo Minssen
affiliation not provided to SSRN and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

64.

Innovation and Intellectual Property Policies in European Research Infrastructure Consortia — Part I: The Case of the European Spallation Source ERIC

Journal of Intellectual Property Law & Practice, Vol. 12, No. 5, 27.03.2017, p. 384–397. https://doi.org/10.1093/jiplp/jpx022
Posted: 17 Oct 2020
Helen Yu, Jakob Wested and Timo Minssen
University of Copenhagen - Center for Information and Innovation Law (CIIR), Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

65.

Will the EPO’s Enlarged Board of Appeal Hear the Broad's CRISPR Case?

In: Life Sciences Intellectual Property Review (LSIPR), No. 13/7 2018, 13.07.2018. https://www.lifesciencesipreview.com/article/will-the-epo-s-enlarged-board-hear-the-broad-s-crispr-case
Posted: 04 Sep 2020 Last Revised: 08 Sep 2020
Jakob Wested, Timo Minssen and Esther van Zimmeren
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Centre of Excellence GOVTRUST, University of Antwerp, Belgium

Abstract:

Loading...

66.

The Legal Dimensions of Big Data, Artificial Intelligence and Machine Learning in Pharmaceutical Innovation (Original Title in Accepted Version): Editorial to Special Issue of the European Pharmaceutical Law Review on 'Big Data, AI & Machine Learning in Pharmaceutial Innovation'

Minssen, T. , & Seitz, C. Editorial European Pharmaceutical Law Review, Volume 3, Issue 4 (2019) pp. 139 - 141 DOI: 10.21552/eplr/2019/4/3
Posted: 18 Aug 2020
Timo Minssen and Claudia Seitz
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Ghent, Faculty of Law

Abstract:

Loading...

67.

Mayo’s Impact on Patent Applications Related to Biotechnology, Diagnostics and Personalized Medicine

Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine. / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen; Minssen, Timo; Liddicoat, Johnathan, Nature Biotechnology, Vol. 37, 05.2019, p. 513-518.
Posted: 18 Aug 2020
LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Cambridge - Faculty of Law

Abstract:

Loading...

68.

Ethical and Legal Issues of Ingestible Electronic Sensors

Nat Electron 2, 329–334 (2019). https://doi.org/10.1038/s41928-019-0290-6
Posted: 18 Aug 2020 Last Revised: 07 Jul 2021
Sara Gerke, Timo Minssen, Helen Yu and I. Glenn Cohen
Pennsylvania State University, Dickinson Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen - Center for Information and Innovation Law (CIIR) and Harvard Law School

Abstract:

Loading...

69.

One Year After Vanda, Are Diagnostics Patents Transforming Into Methods of Treatment to Overcome Mayo-Based Rejections?

One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections? / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen ; Davey, Neal; Liddicoat, Johnathan; Minssen, Timo., Nature Biotechnology, Vol. 38, 09.03.2020, p. 279–283.
Posted: 18 Aug 2020
LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, affiliation not provided to SSRN, University of Cambridge - Faculty of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

70.

How Does Emerging Patent Case Law in the US and Europe Affect Precision Medicine? How Will Today’s Patent Law Affect Tomorrow’s Innovation in the Areas of Biomarkers and Nature-Based Products; Diagnostics; and Algorithms, Big Data and AI?

Aboy, M., Liddell, K., Crespo, C. et al. How does emerging patent case law in the US and Europe affect precision medicine?. Nat Biotechnol 37, 1118–1125 (2019)
Posted: 18 Aug 2020
LML, University of Cambridge, Harvard Law School, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law, University of Cambridge, Pennsylvania State University, Dickinson Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

71.

Establishing the First International Genetic Discrimination Observatory

Joly, Y., Dalpé, G., Dupras, C. et al. Establishing the International Genetic Discrimination Observatory. Nat Genet 52, 466–468 (2020)
Posted: 18 Aug 2020
Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

72.

An EU Comparative Analysis of the Regulation of Clinical Trials Supervisory Bodies in the Aftermath of Regulation 536/2014

An EU Comparative Analysis of the Regulation of Clinical Trials Supervisory Bodies in the Aftermath of Regulation 536/2014. de Miguel Beriain, Iñigo; Minssen, Timo; Chortara, Theodora; Duardo-Sánchez, Aliuska; Feeney, Oliver; Felzmann, Heike; Fernández de Uzquiano, Emma; Lievevrouw, Elisa
Posted: 14 Aug 2020
Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

73.

The European Artificial Intelligence Strategy: Implications and Challenges for Digital Health

2 THE LANCET DIGITAL HEALTH E376 (2020). https://doi.org/10.1016/S2589-7500(20)30112-6
Posted: 14 Aug 2020 Last Revised: 07 Jul 2021
Harvard Law School, INSEAD, Pennsylvania State University, Dickinson Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

Artificial Intelligence, European Commission, White Paper

74.

The EU-US Privacy Shield Regime for Cross- Border Transfers of Personal Data under the GDPR: What are the legal challenges and how might these affect cloudbased technologies, big data, and AI in the medical sector?

Lexxion, 2020
Posted: 14 Aug 2020
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Ghent, Faculty of Law, LML, University of Cambridge and Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen

Abstract:

Loading...

75.

Regulatory Responses to Medical Machine Learning

Journal of Law and the Biosciences, Volume 7, Issue 1, January-June 2020, lsaa002, https://doi.org/10.1093/jlb/lsaa002
Posted: 14 Aug 2020 Last Revised: 07 Jul 2021
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Pennsylvania State University, Dickinson Law, LML, University of Cambridge, University of Michigan Law School and Harvard Law School

Abstract:

Loading...

Medical Devices, Artificial Intelligence, Regulation

76.

When Does Stand-Alone Software Qualify As a Medical Device in the European Union? The CJEU Decision in SNITEM and What It Implies for the Next Generation of Medical Devices

When Does Stand-Alone Software Qualify As a Medical Device in the European Union? The CJEU decision in SNITEM and What It Implies for the Next Generation of Medical Devices. Minssen, Timo; Mimler, Marc; Mak, Vivian. In: Medical Law Review, Vol. 28, No. 3, 01.07.2020, p. 1-10
Posted: 14 Aug 2020
Timo Minssen, Marc Mimler and Vivian Mak
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Bournemouth University - Centre for Intellectual Property Policy & Management (CIPPM) and Vivian Mak Professional Services, Winchester, UK

Abstract:

Loading...

eHealth, Health care, Medical devices, Medical Devices Directive, Software

77.

Germany's 2019 Digital Health Reforms in the Era of Covid-19: Lessons and Opportunities for Other Countries

npj Digital Medicine volume 3, Article number: 94 (2020)
Posted: 20 Jul 2020
Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

Health policy, Health services

78.

Big Data in the Health and Life Sciences: What Are the Challenges for European Competition Law and Where Can They Be Found?

CEIPI / ICTSD Publication Series on Global Perspectives and Challenges for the Intellectual Property System, 2018. p. 121-130.
Posted: 26 Aug 2019
Timo Minssen and Jens Schovsbo
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Centre for Information and Innovation Law (CIIR)

Abstract:

Loading...

79.

US Declatory Judgment Jurisdiction and the U.S. Supreme Court Decision InMedImmune (Zur Zulässigkeit von Feststellungsklagen im US Lizensrecht nach den Entscheidungen in MedImmune und SanDisk)

Gewerblicher Rechtsschutz und Urheberrecht. Internationaler Teil, Vol. 57, No.3, pp. 192-200, 2008
Posted: 27 Jun 2019
Timo Minssen and Gösta Schindler
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and affiliation not provided to SSRN

Abstract:

Loading...

80.

Much Ado About Something: Legal, Ethical and Scientific Challenges in International Biobanking and Translational Exploitation

Global Genes, Local Concerns- Legal, Ethical and Scientific Challenges in International Biobanking.. ed. / Timo Minssen; Janne Rothmar Herrmann; Jens Schovsbo. Edward Elgar Publishing, 2019. ISBN 9781788116183
Posted: 26 Apr 2019
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen - Faculty of Law and Centre for Information and Innovation Law (CIIR)

Abstract:

Loading...

81.

Clinical Trials Data Transparency & GDPR Compliance: What Are the Effects on Data Sharing and Open Innovation?

In : Katerina Sideri & Graham Dutfield (eds.), Openness, Intellectual Property and Science Policy in the Age of Data Driven Medicine, Special Issue of Science and Public Policy (2019)
Posted: 25 Apr 2019 Last Revised: 18 Jul 2019
Timo Minssen, Rajam Neethu and Marcel Bogers
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen and Eindhoven University of Technology

Abstract:

Loading...

82.

Shadow Health Records Meet New Data Privacy Laws

Science, Vol. 363, No. 6426, 01.02.2019, p. 448-450., U of Colorado Law Legal Studies Research Paper No. 19-13
Posted: 25 Apr 2019 Last Revised: 16 Jul 2020
University of Michigan Law School, University of Michigan at Ann Arbor - Medical School, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Colorado Law SchoolYale University - Yale Information Society Project

Abstract:

Loading...

83.

What Lurks in the Shadows of the Openness Hyperbole for Biopharmaceuticals?

What lurks in the shadows of the openness hyperbole for biopharmaceuticals? / Rajam, Neethu; Minssen, Timo. In: Drug Development Research, Vol. 80, No. 3, 11.05.2019, p. 282-284. https://doi.org/10.1002/ddr.21526
Posted: 25 Apr 2019 Last Revised: 06 Nov 2020
Rajam Neethu and Timo Minssen
University of Copenhagen and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

An 'Export-Only' Exception to Pharmaceutical Patents in Europe: Should the U.S. Follow Suit?

Nature Biotechnology, Vol. 37, No. 1, 03.01.2019, p. 21-22.
Posted: 24 Apr 2019
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Brigham and Women's Hospital/Harvard Medical School and Harvard Medical School

Abstract:

Loading...

An 'Export-Only' Exception to Pharmaceutical Patents in Europe: Should the U.S. Follow Suit?

Nature Biotechnology, Vol.37, No. 1, pp. 21-22 (2019); DOI: 10.1038/nbt.4324
Posted: 27 Jun 2019
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Brigham and Women's Hospital/Harvard Medical School and Harvard Medical School

Abstract:

Loading...

85.

Will the EPO’s Enlarged Board Hear the Broad’s CRISPR Case?

Life Sciences Intellectual Property Review (LSIPR), No. 13/7 2018, 13.07.2018.
Posted: 24 Apr 2019
Jakob Wested, Timo Minssen and Esther van Zimmeren
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Centre of Excellence GOVTRUST, University of Antwerp, Belgium

Abstract:

Loading...

86.

Clearing a Way Through the CRISPR Patent Jungle

Life Sciences Intellectual Property Review (LSIPR), No. 8/5 2018, 2018.
Posted: 24 Apr 2019
Timo Minssen, Esther van Zimmeren and Jakob Wested
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Centre of Excellence GOVTRUST, University of Antwerp, Belgium and Centre for Advanced Studies in Biomedical Innovation Law (CeBIL)

Abstract:

Loading...

87.

Big Data and Intellectual Property Rights in the Health and Life Sciences

Cambridge University Press, Big Data, Health Law, and Bioethics, 2018. p. 311-323.
Posted: 24 Apr 2019
Timo Minssen and Justin Pierce
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University - Faculty of Law

Abstract:

Loading...

88.

A Ray of Light in Muddy Waters? -The CJEU Rules on Combination SPCs in C-121/17 Teva v Gilead

European Pharmaceutical Law Review, Vol. 2, No. 3, 2018, p. 169-173.
Posted: 24 Apr 2019
Timo Minssen and Sven Bostyn
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Copenhagen - Faculty of Law

Abstract:

Loading...

Other Papers (1)

Total Downloads: 32
1.

Why U.S. Support for the COVID IP Waiver Won't Solve the Vaccine Problem

A shortened and edited version of this letter was published in The Financial Times on May 12th 2021
Number of pages: 2 Posted: 08 Jul 2021
Duncan Matthews and Timo Minssen
Queen Mary University of London - School of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 32

Abstract:

Loading...

Health Law, Life Science Law, COVID-19, Vaccinations